Frequently Asked Questions
What is the Physician Payments Sunshine Act?
The Physician Payments Sunshine Act (part of the ACA) requires pharmaceutical and medical device manufacturers to report to CMS all payments and transfers of value made to physicians and teaching hospitals annually. The goal is transparency — patients and the public can see which doctors receive payments from drug and device companies, and for what purpose.
Does receiving payments from a pharmaceutical company mean a doctor is biased?
Not necessarily. Payments include many legitimate activities: serving as a clinical trial investigator, providing medical education, consulting on drug development, or speaking at continuing medical education events. The data shows what was paid and for what category — it does not establish whether any specific payment influenced prescribing behavior. Research on this topic shows mixed results.
How many companies and doctors are in the database?
PlainPharmaWatch covers 1,729 pharmaceutical and medical device companies that reported payments in Program Year 2024, and shows individual profiles for the 10,000 highest-paid physician and teaching hospital recipients. Aggregate totals include all recipients.
What is the difference between general payments and research payments?
General payments cover direct transfers of value — consulting fees, food and beverage, speaking fees, travel, gifts, education, royalties, and others. Research payments cover compensation related to formal research activities, such as investigator fees for clinical trials. These are tracked separately by CMS because research relationships have different regulatory implications than direct commercial payments.
My doctor appears in the database. Should I be concerned?
Appearing in the database means your doctor received at least one reported payment from a pharmaceutical or device company. Review the payment type and amount. Food and beverage ($20 lunch at a CME event) is very different from $50,000 in consulting fees. If you have concerns about potential conflicts of interest, you can discuss them directly with your provider.
How current is the data?
PlainPharmaWatch uses CMS Open Payments Program Year 2024 data. CMS publishes annual data approximately 12 months after the program year ends. We update our database when new CMS annual data is released.
Is PlainPharmaWatch affiliated with CMS or any pharmaceutical company?
No. PlainPharmaWatch is an independent project and is not affiliated with the Centers for Medicare & Medicaid Services, any pharmaceutical company, or any healthcare organization. We present publicly available government data to make it more accessible.